LU K73 (Quetiapine Fumarate Extended-Release 200 mg)
Pill with imprint LU K73 is Yellow, Capsule-shape and has been identified as Quetiapine Fumarate Extended-Release 200 mg. It is supplied by Lupin Pharmaceuticals, Inc..
Quetiapine is used in the treatment of bipolar disorder; schizoaffective disorder; schizophrenia; depression; major depressive disorder and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Quetiapine 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for LU K73
Quetiapine Fumarate Extended-Release
- Imprint
- LU K73
- Strength
- 200 mg
- Color
- Yellow
- Size
- 17.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Atypical antipsychotics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Lupin Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 68180-0614
- Inactive Ingredients
-
microcrystalline cellulose,
ferric oxide yellow,
hypromellose 2208 (15000 mPa.s),
hypromellose 2910 (15000 mPa.s),
hypromelloses,
lactose monohydrate,
magnesium stearate,
polyethylene glycol 400,
titanium dioxide,
trisodium citrate dihydrate
Note: Inactive ingredients may vary.
More about quetiapine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 1774 Reviews
- Drug class: atypical antipsychotics
- FDA Alerts (4)
Consumer resources
- Patient Information
- Quetiapine (Advanced Reading)
- Quetiapine Extended-Release Tablets
- Quetiapine Tablets
- Other brands
- Seroquel, Seroquel XR
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.